Kinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3-35: a new peptide generated by plasma kallikrein.
about
The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviourRole of plasma kallikrein in diabetes and metabolismNeuropeptide Y is produced by adipose tissue macrophages and regulates obesity-induced inflammationNeuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment.Prolylcarboxypeptidase (PRCP) as a new target for obesity treatmentMicellar nanomedicine of human neuropeptide Y.NPY receptors as potential targets for anti-obesity drug development.The anorexic hormone Peptide YY3-36 is rapidly metabolized to inactive Peptide YY3-34 in vivoIdentification of an intracellular M17 family leucine aminopeptidase that is required for virulence in Staphylococcus aureus.Neuropeptide Y3-36 incorporated into PVAX nanoparticle improves functional blood flow in a murine model of hind limb ischemia.Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.NPY binds with heme to form a NPY-heme complex: enhancing peroxidase activity in free heme and promoting NPY nitration and inactivation.On the terminal homologation of physiologically active peptides as a means of increasing stability in human serum--neurotensin, opiorphin, B27-KK10 epitope, NPY.In vivo and in vitro degradation of peptide YY3-36 to inactive peptide YY3-34 in humans.Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients.Identification of novel loci affecting circulating chromogranins and related peptides.Proteolytic degradation of neuropeptide Y (NPY) from head to toe: Identification of novel NPY-cleaving peptidases and potential drug interactions in CNS and Periphery.
P2860
Q27002574-2CA7FFF1-1166-4456-A34C-3A9F42257476Q27016431-3F3DF8EE-7EFC-483C-9511-2CD4CF2867D5Q27312241-EDAECAB3-0EC0-45D1-9984-121DD33BB19FQ30315395-F27D99F6-841E-4E06-860E-1A69C5600170Q34046650-3E705676-0B57-4D56-99BC-3445952280ECQ35000999-FFC6FC93-CC51-4C37-98EC-D1579EEF220EQ35130522-EB70A341-9B96-4EDB-AB40-5796AD4E657FQ36004364-2BDF9C2B-EE0D-438F-BB9C-D092B8B5BCE9Q36185933-5DA28A27-42BA-4611-83D3-07C517D3A0DFQ36311441-24DBAAE8-41CA-4433-9109-DF471B5D112EQ38217456-0066B91F-5D6C-4A34-B656-BE140AC98D46Q38665001-1CA0DD26-07DB-4CC5-83A8-3AFE32EC7B6CQ39544807-4A24957F-7C14-4C14-B3B3-79C84154FED3Q40953070-7A936F87-4A96-4EA3-8F55-C58C5308791CQ43669793-DA0FCA89-BBD5-4045-905B-047400BACDBDQ46382432-3BC60240-3AFB-4579-99B1-4ACB2B26A5ACQ52148357-DF8B7C24-F7B0-4CC0-B874-3F44DCF7BD7C
P2860
Kinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3-35: a new peptide generated by plasma kallikrein.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Kinetic study of neuropeptide ...... enerated by plasma kallikrein.
@en
Kinetic study of neuropeptide Y
@nl
type
label
Kinetic study of neuropeptide ...... enerated by plasma kallikrein.
@en
Kinetic study of neuropeptide Y
@nl
prefLabel
Kinetic study of neuropeptide ...... enerated by plasma kallikrein.
@en
Kinetic study of neuropeptide Y
@nl
P2093
P2860
P356
P1476
Kinetic study of neuropeptide ...... enerated by plasma kallikrein.
@en
P2093
Bertrand Rochat
Bilgin Vatansever
Eric Grouzmann
Ingrid De Meester
Jean-Francois Aubert
Karim Abid
Noureddine Brakch
Patricia Tella
Paul-Gerhard Lassahn
Reto Stöcklin
P2860
P304
24715-24724
P356
10.1074/JBC.M109.035253
P407
P577
2009-07-20T00:00:00Z